Subscribe by Email

About the Blog

The Active Ingredient features expert insights and commentary from leaders of ZS Associates' global pharmaceuticals practice.

Search by Topic

see all

How to Get Pharma Leaders to Wrap Their Minds—and Their Arms—Around Advanced Analytics

Posted by Shreyas Murthi on Mon, Mar 11, 2019

 

The business of pharma is becoming more data-driven—from R&D to commercial—yet many pharma companies still struggle to garner leaders’ buy-in to build and operate the analytics programs that they need to fuel their success. They face tough challenges, including overcoming skepticism, proving the program’s value and scalability, finding the right talent and ensuring organizational collaboration.    

Read More

Topics: predictive analytics, Analytics, pharmaceuticals, change management, data analytics, pharma companies, artificial intelligence & pharma, cutting-edge analytics, technology investment, advanced analytics, personalized analytics, analytics maturity

A Medtech Exec, Pharma Exec and Venture Capitalist Walk Onto a Stage and Talk Digital Health

Posted by Pete Masloski on Wed, Feb 13, 2019

Vijesh Unnikrishnan co-wrote this article with Pete Masloski.

This blog post was originally published on ZS's medtech blog, The Pacemaker

It’s not often that you get medtech, pharma and venture capital executives to sit on the same panel and participate with enthusiasm and excitement—unless the topic is digital health, where the cross-pollination of ideas and solutions across industry players is becoming more of a norm than an exception. At ZS’s recent Digital and Connected Health Summit, we were fortunate to host a panel of experts who engaged us in a lively discussion: Andy Atwell, executive director of new business development at Omron; Pankaj Dubey, senior director, U.S. commercial, at Abbvie; Divya Varshney, digital health lead at Baxter; and Megan Zweig, director of research at Rock Health. The panelists shared their excitement and optimism, and some examples of how they see life sciences companies adopting digital health solutions to solve patient needs and drive industry growth.

Read More

Topics: healthcare trends, medtech, pharmaceuticals, trends, digital health, pharma landscape, medtech competition

From Good to Great: To Accelerate Growth, Look Inward

Posted by Yasasvi Popuri on Thu, Nov 08, 2018

How can we identify and realize growth opportunities? That’s the multibillion-dollar question that looms large on the minds of pharma and biotech companies when their drugs enter the maturation phase. In our experience, pharmaceutical and biotech companies take one of two broad approaches to address this problem: understanding and addressing the provider, patient or payer barriers or diving deeper into field force effectiveness to improve the customer experience. The choice of approach depends on whether marketing or sales leadership initiates the franchise-wide pursuit of additional growth opportunities.

Read More

Topics: customers, Growth, strategic accounts, pharmaceuticals, biopharma, product differentiation, growth drivers, growth strategy, data and insights

AI Across the Pond: Implementing Next Best Actions in Europe

Posted by Zainul Jafferji on Wed, Jun 27, 2018

There’s no shortage of news about how artificial intelligence techniques are helping us engage customers better in healthcare. Many pharmaceutical companies have visions of Amazon-like targeting serving up Netflix-esque recommendations on how to engage customers better with the right channels, content and cadence.

Read More

Topics: customer experience, Pharma, pharmaceuticals, personalization, Europe, artificial intelligence, EU, AI, machine learning, next-best actions, european market, artificial intelligence & pharma, personalized analytics

Three Critical Moves for Getting Launch Targeting Right

Posted by Paul Hashemi on Mon, May 14, 2018

It’s common knowledge that the success of a launch sets the long-term trajectory of a pharmaceutical brand. In past decades, companies would double down on their research investments with massive sales forces, reaching every plausible potential prescriber, but in today’s environment, promotional resources often are limited. This means that targeting the right customers is increasingly important to ensuring that a new brand’s launch is successful.

Read More

Topics: go-to-market strategy, product launch, Pharmaceutical Companies, Pharmaceutical Marketing, pharmaceuticals, commercial strategy, pharma brands, launch targeting

Subscribe to The Active Ingredient
SUBSCRIBE

Get 'THE ACTIVE INGREDIENT' Updates

Subscribe to receive email notifications whenever new blog posts are published.

×